Status:
COMPLETED
AI Multitask Model for HCC Treatment
Lead Sponsor:
Sun Yat-sen University
Conditions:
Hepatocellular Carcinoma (HCC)
Eligibility:
All Genders
18-75 years
Brief Summary
We will integrate multi-modal cardiac data via an AI multitask framework to develop and validate concurrent models for liver function, treatment prognosis, and microvascular invasion (MVI) prediction ...
Eligibility Criteria
Inclusion
- age 18-75 years;
- HCC diagnosed according to the European Association for the Study of the Liver/American Association for the Study of Liver Diseases criteria)
- Eastern Cooperative Oncology Group performance status \< 2;
- Child-Pugh class A or B liver function;
Exclusion
- HCC combined with other malignancies;
- missing image data during perioperative period;
- lost to follow-up \> 12 months.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT07157085
Start Date
January 1 2008
End Date
December 31 2023
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou, Guangdong, China